Literature DB >> 22550433

Radiotherapy for head and neck cancer.

Shyh-An Yeh1.   

Abstract

Treatment for patients with head and neck cancer requires a multidisciplinary approach. Radiotherapy is employed as a primary treatment or as an adjuvant to surgery. Each specific subsite dictates the appropriate radiotherapy techniques, fields, dose, and fractionation scheme. Quality of life is also an important issue in the management of head and neck cancer. The radiation-related complications have a tremendous impact on the quality of life. Modern radiotherapy techniques, such as intensity-modulated radiotherapy and image-guided radiotherapy, can offer precise radiation delivery and reduce the dose to the surrounding normal tissues without compromise of target coverage. In the future, efforts should be made in the exploration of novel strategies to improve treatment outcome in patients with head and neck cancer.

Entities:  

Keywords:  Radiotherapy; brachytherapy; head and neck cancer; intensity-modulated

Year:  2010        PMID: 22550433      PMCID: PMC3324252          DOI: 10.1055/s-0030-1255330

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  42 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

2.  T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.

Authors:  D A Fein; W M Mendenhall; J T Parsons; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-03-15       Impact factor: 7.038

3.  Primary radiotherapy of T1 and T2 glottic carcinoma--analysis of treatment results and prognostic factors in 223 patients.

Authors:  C Klintenberg; J Lundgren; G Adell; M Tytor; L Norberg-Spaak; R Edelman; J M Carstensen
Journal:  Acta Oncol       Date:  1996       Impact factor: 4.089

4.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy.

Authors:  W M Mendenhall; R J Amdur; C G Morris; R W Hinerman
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

5.  Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.

Authors:  M S Kies; D J Haraf; I Athanasiadis; M Kozloff; B Mittal; H Pelzer; A W Rademaker; B Wenig; R R Weichselbaum; E E Vokes
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

6.  Postoperative radiation of free jejunal autografts in patients with advanced cancer of the head and neck.

Authors:  C J Cole; A S Garden; R A Frankenthaler; G P Reece; W H Morrison; K K Ang; L J Peters
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

7.  Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma.

Authors:  M J Zelefsky; L B Harrison; J G Armstrong
Journal:  Cancer       Date:  1992-11-15       Impact factor: 6.860

8.  Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy.

Authors:  J G Armstrong; L B Harrison; R H Spiro; D E Fass; E W Strong; Z Y Fuks
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1990-03

9.  Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.

Authors:  Patrizia Olmi; Sergio Crispino; Carlo Fallai; Valter Torri; Francesca Rossi; Andrea Bolner; Maurizio Amichetti; Marco Signor; Raffaella Taino; Massimo Squadrelli; Alessandro Colombo; Alessandro Ardizzoia; Pietro Ponticelli; Giovanni Franchin; Emilio Minatel; Carlo Gobitti; Guido Atzeni; Alessandro Gava; Monica Flann; Silvia Marsoni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

10.  A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.

Authors:  F G LeVeque; M Montgomery; D Potter; M B Zimmer; J W Rieke; B W Steiger; S C Gallagher; C C Muscoplat
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544

View more
  13 in total

1.  Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.

Authors:  Madhup Rastogi; Rohini Khurana; Swaroop Revannasiddaiah; Isha Jaiswal; Sambit S Nanda; Pooja Gupta; Kundan S Chufal; M L Bhatt
Journal:  Support Care Cancer       Date:  2016-12-16       Impact factor: 3.603

2.  Cross-institutional outcome prediction for head and neck cancer patients using self-attention neural networks.

Authors:  William Trung Le; Eugene Vorontsov; Francisco Perdigón Romero; Lotfi Seddik; Mohamed Mortada Elsharief; Phuc Felix Nguyen-Tan; David Roberge; Houda Bahig; Samuel Kadoury
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

3.  Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro.

Authors:  Tobias Maier; Stefan Stoiber; Lorenz Kadletz-Wanke; Faris F Brkic; Elisabeth Gurnhofer; Markus Haas; Lukas Kenner; Gregor Heiduschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-24       Impact factor: 3.236

Review 4.  Insight into Salivary Gland Aquaporins.

Authors:  Claudia D'Agostino; Osama A Elkashty; Clara Chivasso; Jason Perret; Simon D Tran; Christine Delporte
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

5.  Deep learning in head & neck cancer outcome prediction.

Authors:  André Diamant; Avishek Chatterjee; Martin Vallières; George Shenouda; Jan Seuntjens
Journal:  Sci Rep       Date:  2019-02-26       Impact factor: 4.379

Review 6.  Prognostic Value of MiR-21: An Updated Meta-Analysis in Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors:  Alexandra Iulia Irimie-Aghiorghiesei; Cecilia Pop-Bica; Sebastian Pintea; Cornelia Braicu; Roxana Cojocneanu; Alina-Andreea Zimța; Diana Gulei; Ondřej Slabý; Ioana Berindan-Neagoe
Journal:  J Clin Med       Date:  2019-11-21       Impact factor: 4.241

7.  Radiomic features based on Hessian index for prediction of prognosis in head-and-neck cancer patients.

Authors:  Quoc Cuong Le; Hidetaka Arimura; Kenta Ninomiya; Yutaro Kabata
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

Review 8.  Nutritional Deficiencies in Radiotherapy-Treated Head and Neck Cancer Patients.

Authors:  Tomasz Powrózek; Joanna Dziwota; Teresa Małecka-Massalska
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

9.  A Novel Murine Model of Radiation Keratopathy.

Authors:  Deshea L Harris; Takefumi Yamaguchi; Pedram Hamrah
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

10.  Head and Neck Cancer Patients' Quality of Life: Analysis of Three Instruments.

Authors:  Elâine Patrícia Alves de Araújo Gomes; Andreza Maria Fabio Aranha; Alvaro Henrique Borges; Luiz Evaristo Ricci Volpato
Journal:  J Dent (Shiraz)       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.